Table 27.

Registered treatments that are not reimbursed [2]

Treatment	Countries where reimbursement is not offered for osteoporosis
Risedronate	Estonia, Malta
Alendronate	Malta
Ibandronate	Malta, Poland, Sweden
Zoledronic acid	Estonia, Malta, Poland, Romania
Raloxifene	Bulgaria, Latvia, Malta, Poland
Denosumab	Estonia, France, Malta, Portugal, Romania
Strontium Ranelate	Malta, Poland
Teriparatide and PTH (1–84)	Bulgaria, Estonia, Luxembourg, Malta, Netherlands, Poland, Romania
Alfacalcidol/calcitriol	Belgium, Denmark, France, Ireland, Poland